Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer, +66

Cancer Discovery

Assessment of Disease Dissemination in Gastric Compared With Extragastric Mucosa-Associated Lymphoid Tissue Lymphoma Using Extensive Staging: A Single-Center Experience

Markus Raderer, Stefan Wöhrer, Berthold Streubel, +11

Journal of Clinical Oncology

Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy

Edit Porpaczy, Sabrina Tripolt, Andrea Hoelbl‐Kovacic, +34

Blood

Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

Marius E. Mayerhoefer, Georgios Karanikas, Kurt Kletter, +17

Clinical Cancer Research

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response

Ulrich Jäger, Michael Fridrik, Markus Zeitlinger, +13

Haematologica

MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course

Stefan Wöhrer, Marlene Troch, Berthold Streubel, +8

Leukemia

Primary ImmunodeficiencyLymphoid NeoplasiaAutoimmune DiseaseImmunodeficienciesImmunology +9

Autoimmune thrombocytopenia in non-Hodgkin's lymphomas

Alexander W. Hauswirth, Cathrin Skrabs, Christian Schützinger, +5

Haematologica

ImmunohematologyImmunologyPathologyLymphomas PatientsImmunotherapy +14

Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

Martin Filipits, Ulrich Jaeger, Gudrun Pohl, +5

PubMed

Hematological MalignancyTumor BiologyLymphoid NeoplasiaPrognostic FactorLymphoma Cells +10

Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients

Marius E. Mayerhoefer, Georgios Karanikas, Kurt Kletter, +14

Clinical Cancer Research

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Ulrich Jaeger, Marek Trněný, Helen Melzer, +19

Haematologica

Hematological MalignancyLymphoid NeoplasiaRituximab Maintenance TherapyAggressive B-cell LymphomaMedicine +12